Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:33
  • preuzimanja u poslednjih 30 dana:1

Sadržaj

članak: 7 od 71  
Back povratak na rezultate
2018, vol. 75, br. 10, str. 968-977
Prognostička vrednost presepsina (solubilnog CD 14-podtipa) u dijagnozi pneumonija povezanih sa mehaničkom ventilacijom i sepse kod traumatizovanih bolesnika
aUniverzitet u Beogradu, Medicinski fakultet + Klinički centar Srbije, Centar za anesteziologiju i reanimatologiju, Beograd
bUniverzitet u Beogradu, Medicinski fakultet + Univerzitet u Beogradu, Medicinski fakultet, Institut za epidemiologiju
cUniverzitet u Beogradu, Medicinski fakultet + Klinički centar Srbije, Centar za medicinsku biohemiju, Beograd
dUniverzitet u Beogradu, Medicinski fakultet + Klinički centar Srbije, Urgentni centar, Klinika za urgentnu hirurgiju , Beograd
eKlinički centar Srbije, Centar za medicinsku biohemiju, Beograd
fUniverzitet u Beogradu, Medicinski fakultet, Institut za farmakologiju, kliničku farmakologiju i toksikologiju

e-adresabjovanovic@outlook.com
Projekat:
Kliničko epidemiološka istraživanja najčešćih neželjenih događaja tokom bolničkog lečenja (MPNTR - 175046)

Ključne reči: presepsin protein; humani; pneumonija; respiratorom uzrokovana; sepsa; šok; spetički; biološki pokazatelji; senzitivnost i specifičnost; dijagnoza
Sažetak
Uvod/Cilj. Persepsin (solubilni CD14-podtip) je fragment CD14 koji se produkuje kao odgovor na prisustvo bakterijske infekcije i predstavlja novi biomarker u dijagnostici pneumonije, sepse i spetičkog šoka. Cilj ove studije bio je da se uporedi senzitivnost i specifičnost presepsina (solubilnog CD14-podtipa) sa ostalim biomarkerima infekcije: prokalcitoninom (PCT), C-reaktivnim proteinom (CRP) i brojem leukocita (Le) kod povređenih bolesnika na mehaničkoj ventilaciji, kao markera pneumonije, sepse i septičkog šoka. Metode. Prospektivna studija sprovedena je u dve jedinice intenzivnog lečenja (JIL) (traumatološka i hirurška) Kliničkog centra Srbije u periodu od januara do aprila 2013. godine. U studiju je bilo uključeno 39 traumatizovanih bolesnika na mehaničkoj ventilaciji kod kojih se razvio neki od sledećih ishoda koji su bili i kriterijumi za uključivanje: sisemski inflamatorni odgovor (SIRS), pneumonija povezana sa mehaničkom ventilacijom (VAP), sepsa i/ili septički šok. Na prijemu u JIL Acute Physiology and Chronic Health Evaluation II (APACHE II) skor i Injury Severity Score (ISS) su računati za svakog bolesnika. Sedamdeset i dva merenja koncentracije četiri biomarkera (presepsin, PCT, CRP i Le) urađena su kod 39 bolesnika u trenutku postavljanja dijagnoze SIRS, VAP, sepse i/ili septičkog šoka. Sequential Organ Failure Assessment (SOFA) skor takođe je meren istovremeno. Rezultati. Većina bolesnika na prijemu bila je teško povređena (srednja vrednost ISS skora = 24.2) i bila je u srednje teškom stanju (srednja vrednost APACHE II skora = 14.5). Koncentracije presepsina značajno su se razlikovale između sve četiri grupe bolesnika, osim između grupa sa sepsom i septičkim šokom. Najsnažniju pozitivnu korelaciju presepsin je imao sa PCT (r = 0.741, p < 0.001). sCD14-ST pokazao je bolju prediktivnu vrednost u dijagnozi pneumonije (AUC = 0.909) i sepse (AUC = 0.899) u odnosu na PCT (AUCs: 0.863, 0.855), CRP (AUCs: 0.703, 0.677) i Le (AUCs: 0.688, 0.700). Zaključak. Ova studija je pokazala da je sCD14-ST pouzdan biomarker u određivanju težine sepse kao i da je u dobroj korelaciji sa nastankom infekcije i pogoršanjem stanja kod povređenih bolesnika.
Reference
Agbaht, K., Lisboa, T., Pobo, A., Rodriguez, A., Sandiumenge, A., Diaz, E., Rello, J. (2007) Management of ventilator-associated pneumonia in a multidisciplinary intensive care unit: does trauma make a difference?. Intensive Care Medicine, 33(8): 1387-1395
American Thoracic Society (2005) Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med, 171(4); 388-416
Bekaert, M., Timsit, J., Vansteelandt, S., Depuydt, P., Vésin, A., Garrouste-Orgeas, M., Decruyenaere, J., Clec'h, C., Azoulay, E., Benoit, D. (2011) Attributable Mortality of Ventilator-Associated Pneumonia. American Journal of Respiratory and Critical Care Medicine, 184(10): 1133-1139
Chenevier-Gobeaux, C., Borderie, D., Weiss, N., Mallet-Coste, T., Claessens, Y. (2015) Presepsin (sCD14-ST), an innate immune response marker in sepsis. Clinica Chimica Acta, 450: 97-103
Cinel, I., Opal, S.M. (2009) Molecular biology of inflammation and sepsis: A primer*. Critical Care Medicine, 37(1): 291-304
Clarke-Pearson, D.L. (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics, 44(3): 837-45
Dellinger, R.P., Levy, M.M., Rhodes, A., Annane, D., Gerlach, H., Opal, S.M., Sevransky, J.E., Sprung, C.L., Douglas, I.S., Jaeschke, R., Osborn, T.M., Nunnally, M.E., Townsend, S.R., Reinhart, K. (2013) Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Medicine, 39(2): 165-228
Dombrovskiy, V.Y., Martin, A.A., Sunderram, J., Paz, H.L. (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003*. Critical Care Medicine, 35(5): 1244-1250
Endo, S., Suzuki, Y., Takahashi, G., Shozushima, T., Ishikura, H., Murai, A., Nishida, T., Irie, Y., Miura, M., Iguchi, H., Fukui, Y., Tanaka, K., Nojima, T., Okamura, Y. (2012) Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study. Journal of Infection and Chemotherapy, 18(6): 891-897
Enguix-Armada, A., Escobar-Conesa, R., la Torre, A.G., de La, T.M.V. (2016) Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. Clinical Chemistry and Laboratory Medicine (CCLM), 54(1): 163-8
Fagon, J. (2011) Biological markers and diagnosis of ventilator-associated pneumonia. Critical Care, 15(2): 130
Jovanovic, B., Milan, Z., Markovic-Denic, L., Djuric, O., Radinovic, K., Doklestic, K., Velickovic, J., Ivancevic, N., Gregoric, P., Pandurovic, M., Bajec, D., Bumbasirevic, V. (2015) Risk factors for ventilator-associated pneumonia in patients with severe traumatic brain injury in a Serbian trauma centre. International Journal of Infectious Diseases, 38: 46-51
Kalanuria, A., Zai, W., Mirski, M. (2014) Ventilator-associated pneumonia in the ICU. Critical Care, 18(2): 208
Klouche, K., Cristol, J.P., Devin, J., Gilles, V., Kuster, N., Larcher, R., Amigues, L., Corne, P., Jonquet, O., Dupuy, A.M. (2016) Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients. Annals of Intensive Care, 6(1):
Kojic, D. (2015) Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?. World Journal of Experimental Medicine, 5(2): 50
Liu, B., Yin, Q., Chen, Y., Zhao, Y., Li, C. (2014) Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department. Respiratory Medicine, 108(8): 1204-1213
Masson, S., Caironi, P., Fanizza, C., Thomae, R., Bernasconi, R., Noto, A., Oggioni, R., Pasetti, G.S., Romero, M., Tognoni, G., Latini, R., Gattinoni, L. (2015) Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial. Intensive Care Medicine, 41(1): 12-20
Nair, G.B., Niederman, M.S. (2015) Ventilator-associated pneumonia: present understanding and ongoing debates. Intensive Care Medicine, 41(1): 34-48
Okamura, Y., Yokoi, H. (2011) Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clinica Chimica Acta, 412(23-24): 2157-2161
Palazzo, S.J., Simpson, T., Schnapp, L. (2011) Biomarkers for ventilator-associated pneumonia: Review of the literature. Heart & Lung, 40(4): 293-298
Pierrakos, C., Vincent, J. (2010) Sepsis biomarkers: a review. Critical Care, 14(1): R15
Popov, D., Plyushch, M., Ovseenko, S., Abramyan, M., Podshchekoldina, O., Yaroustovsky, M. (2015) Anaesthesiology and intensive care prognostic value of scd14-st (presepsin) in cardiac surgery. Polish Journal of Cardio-Thoracic Surgery, 1: 30-36
Póvoa, P. (2008) Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Current Opinion in Infectious Diseases, 21(2): 157-162
Sandquist, M., Wong, H.R. (2014) Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Review of Clinical Immunology, 10(10): 1349-1356
Schuetz, P., Amin, D.N., Greenwald, J.L. (2012) Role of Procalcitonin in Managing Adult Patients With Respiratory Tract Infections. Chest, 141(4): 1063-1073
Shehabi, Y., Sterba, M., Garrett, P.M., Rachakonda, K.S., Stephens, D., Harrigan, P., Walker, A., Bailey, M.J., Johnson, B., Millis, D., Ding, G., Peake, S., Wong, H., Thomas, J., Smith, K. (2014) Procalcitonin Algorithm in Critically Ill Adults with Undifferentiated Infection or Suspected Sepsis. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine, 190(10): 1102-1110
Shozushima, T., Takahashi, G., Matsumoto, N., Kojika, M., Endo, S., Okamura, Y. (2011) Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. Journal of Infection and Chemotherapy, 17(6): 764-769
Tanriverdi, H., Tor, M., Kart, L., Altin, R., Atalay, F., SumbSümbüloglu, V. (2015) Prognostic value of serum procalcitonin and C-reactive protein levels in critically ill patients who developed ventilator-associated pneumonia. Annals of Thoracic Medicine, 10(2): 137
Vincent, J. (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA, 302(21): 2323
Vodnik, T., Kaljevic, G., Tadic, T., Majkic-Singh, N. (2013) Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis. Clinical Chemistry and Laboratory Medicine, 51(10): 2053-62
Wacker, C., Prkno, A., Brunkhorst, F.M., Schlattmann, P. (2013) Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. Lancet Infectious Diseases, 13(5): 426-435
Waters, B., Muscedere, J. (2015) A 2015 Update on Ventilator-Associated Pneumonia: New Insights on Its Prevention, Diagnosis, and Treatment. Current Infectious Disease Reports, 17(8):
Zhang, X., Liu, D., Liu, Y., Wang, R., Xie, L. (2015) The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis. Critical Care, 19(1):
 

O članku

jezik rada: engleski
vrsta rada: izvorni naučni članak
DOI: 10.2298/VSP161104027J
objavljen u SCIndeksu: 25.10.2018.
metod recenzije: dvostruko anoniman
Creative Commons License 4.0